Who is sponsoring NCT00414284?

NCT00414284 is sponsored by Community Research Initiative of New England.

What condition does NCT00414284 study?

NCT00414284 studies HIV Infections.

What drugs are being tested in NCT00414284?

Interventions: Increased dose of Kaletra.

What is the status of NCT00414284?

NCT00414284 is currently TERMINATED.

Last reviewed 2010-12-06 · How we verify

Evaluation of the Pharmacokinetics and Tolerability of Increased Dosage of Lopinavir/Ritonavir(LPV/r) in Individuals Experiencing Viremia on Standard Dose LPV/r Using LPV/r Tablet Formulation

NCT00414284 Phase 4 TERMINATED

This study will look to see if increasing the standard dose of Kaletra is tolerated and if it will lower viral loads to undetectable levels. This study will also look at the pharmacokinetic data (amount of Kaletra in blood at different times).

Details

Lead sponsor	Community Research Initiative of New England
Phase	Phase 4
Status	TERMINATED
Start date	2006-06
Completion	2007-04

Conditions

HIV Infections

Interventions

Increased dose of Kaletra

Primary outcomes

To evaluate the pharmacokinetic parameters of higher doses of LPV/r

Countries

United States